Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/21 → 12/31/21 |
Funding
- Ann & Robert H. Lurie Children's Hospital of Chicago (Agmt 5/19/21 // Agmt 5/19/21)
- Pfizer Inc. (Agmt 5/19/21 // Agmt 5/19/21)
PDE4A Expression as a Biomarker for Responsiveness to Eucrisa: Pfizer Tracking Number 52504093
- Rangel, Stephanie M (PD/PI)
Project: Research project